Cardiff Oncology's market cap is currently $219.25M. The company's EPS TTM is €; its P/E ratio is ―; Cardiff Oncology is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is €-0.24. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 488.00K	$ 386.00K	$ 359.00K	$ 365.99K	$ 245.00K
Gross Profit	$ 488.00K	$ 186.00K	$ -141.00K	$ -10.87M	$ -10.92M
Operating Income	$ -45.41M	$ -39.90M	$ -28.86M	$ -19.09M	$ -16.68M
EBITDA	$ -45.01M	$ -39.67M	$ -28.40M	$ -18.84M	$ -15.92M
Net Income	$ -41.44M	$ -37.51M	$ -27.74M	$ -19.28M	$ -16.15M
Balance Sheet
Cash & Short-Term Investments	$ 74.82M	$ 105.27M	$ 140.82M	$ 130.98M	$ 10.20M
Total Assets	$ 81.64M	$ 116.19M	$ 149.54M	$ 134.73M	$ 13.09M
Total Debt	$ 2.15M	$ 2.71M	$ 3.12M	$ 869.50K	$ 1.73M
Net Debt	$ -19.51M	$ -13.63M	$ -8.82M	$ -130.11M	$ -8.47M
Total Liabilities	$ 11.90M	$ 9.85M	$ 9.13M	$ 6.57M	$ 5.78M
Stockholders' Equity	$ 69.74M	$ 106.34M	$ 140.42M	$ 128.16M	$ 7.31M
Cash Flow
Free Cash Flow	$ -31.47M	$ -34.71M	$ -23.25M	$ -16.53M	$ -13.34M
Operating Cash Flow	$ -30.89M	$ -33.82M	$ -23.04M	$ -16.31M	$ -13.27M
Investing Cash Flow	$ 36.20M	$ 38.15M	$ -131.45M	$ -211.88K	$ -68.00K
Financing Cash Flow	$ 0.00	$ 75.00K	$ 35.45M	$ 137.31M	$ 12.08M

Currency in USD

Cardiff Oncology Earnings and Revenue History

Income Statement >

Cardiff Oncology Debt to Assets

Balance Sheet >

Cardiff Oncology Cash Flow

Cash Flow >

Cardiff Oncology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing